Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01563406 · ClinicalTrials.gov registry record · NA

Hub Cleansing to Prevent Hub Infection

A NA study, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
149
Enrollment target

NCT01563406 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 149 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01563406, a NA study, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target

Study Summary

Central venous catheter infections are common preventable adverse events among hospital patients. Microbes may enter catheter hubs, also known as needleless connectors, and result in downstream contamination. This study aims to compare alcohol disinfection of catheter hubs to disinfection with chlorhexidine gluconate in alcohol, which has been proven to be a superior disinfectant at the site of central venous catheter insertion. Scrub duration of central venous catheter hubs will also be evaluated.

Interventions

  • DRUG 70% isopropyl alcohol
  • OTHER 15 second scrub
  • OTHER 5 second scrub
  • DRUG 3.15% chlorhexidine/70% isopropyl alcohol

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2012-03
Est. Completion 2013-06
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT01563406

The ClinicalTrials.gov registry entry for NCT01563406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which 70% isopropyl alcohol is the first listed.

NCT01563406 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01563406 about?

NCT01563406 is a clinical study titled "Hub Cleansing to Prevent Hub Infection". Central venous catheter infections are common preventable adverse events among hospital patients. Microbes may enter catheter hubs, also known as needleless connectors, and result in downstream contamination. This study aims to compare alcohol disinfection of catheter hubs to disinfection with chlor...

What is the current status of trial NCT01563406?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2012-03. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01563406?

The interventions under investigation include: 70% isopropyl alcohol (DRUG), 15 second scrub (OTHER), 5 second scrub (OTHER), 3.15% chlorhexidine/70% isopropyl alcohol (DRUG).

Who is sponsoring clinical trial NCT01563406?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.